671 filings
8-K
KTRA
Kintara Therapeutics Inc
25 Apr 24
Regulation FD Disclosure
9:05am
425
KTRA
Kintara Therapeutics Inc
25 Apr 24
Business combination disclosure
9:05am
425
KTRA
Kintara Therapeutics Inc
3 Apr 24
Business combination disclosure
7:15am
8-K
KTRA
Kintara Therapeutics Inc
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
RW
KTRA
Kintara Therapeutics Inc
13 Mar 24
Registration withdrawal request
7:00am
8-K
KTRA
Kintara Therapeutics Inc
27 Feb 24
Other Events
6:59am
8-K
KTRA
Kintara Therapeutics Inc
26 Feb 24
Other Events
7:00am
8-K
KTRA
Kintara Therapeutics Inc
22 Feb 24
Other Events
7:00am
8-K
KTRA
Kintara Therapeutics Inc
14 Feb 24
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
4:10pm
10-Q
2024 Q2
KTRA
Kintara Therapeutics Inc
Quarterly report
14 Feb 24
4:05pm
8-K
KTRA
Kintara Therapeutics Inc
12 Feb 24
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
9:05am
8-K
KTRA
Kintara Therapeutics Inc
18 Dec 23
Other Events
4:10pm
424B5
KTRA
Kintara Therapeutics Inc
18 Dec 23
Prospectus supplement for primary offering
4:05pm
8-K
KTRA
Kintara Therapeutics Inc
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
KTRA
Kintara Therapeutics Inc
7 Dec 23
Kintara Therapeutics Announces Review of Strategic Alternatives
9:10am
8-K
KTRA
Kintara Therapeutics Inc
5 Dec 23
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement
9:10am
8-K
KTRA
Kintara Therapeutics Inc
21 Nov 23
Departure of Directors or Certain Officers
7:55am
8-K
KTRA
Kintara Therapeutics Inc
13 Nov 23
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update
4:15pm
10-Q
2024 Q1
KTRA
Kintara Therapeutics Inc
Quarterly report
13 Nov 23
4:05pm
8-K
KTRA
Kintara Therapeutics Inc
31 Oct 23
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study
8:10am